This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Xenetic Biosciences 미래 성장
Future 기준 확인 1/6
Xenetic Biosciences's earnings are forecast to decline at 37.8% per annum while its annual revenue is expected to grow at 7% per year. EPS is expected to grow by 30.6% per annum.
주요 정보
-37.8%
수익 성장률
30.6%
EPS 성장률
| Biotechs 수익 성장 | 36.4% |
| 매출 성장률 | 7.0% |
| 향후 자기자본 수익률 | n/a |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 16 May 2023 |
최근 미래 성장 업데이트
업데이트 없음
Recent updates
수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2025 | 2 | -17 | N/A | N/A | 1 |
| 12/31/2024 | 2 | -11 | N/A | N/A | 1 |
| 12/31/2023 | 2 | -7 | N/A | N/A | 1 |
| 3/31/2023 | 2 | -6 | -4 | -4 | N/A |
| 12/31/2022 | 2 | -7 | -5 | -5 | N/A |
| 9/30/2022 | 2 | -7 | -6 | -5 | N/A |
| 6/30/2022 | 1 | -7 | -6 | -5 | N/A |
| 3/31/2022 | 1 | -6 | -5 | -5 | N/A |
| 12/31/2021 | 1 | -6 | -5 | -5 | N/A |
| 9/30/2021 | 1 | -5 | -4 | -4 | N/A |
| 6/30/2021 | 1 | -11 | -4 | -4 | N/A |
| 3/31/2021 | 1 | -11 | -5 | -5 | N/A |
| 12/31/2020 | 0 | -11 | -4 | -4 | N/A |
| 9/30/2020 | 0 | -11 | -5 | -5 | N/A |
| 6/30/2020 | 0 | -14 | -6 | -6 | N/A |
| 3/31/2020 | 0 | -14 | -6 | -6 | N/A |
| 12/31/2019 | 0 | -18 | -6 | -6 | N/A |
| 9/30/2019 | N/A | -19 | -6 | -6 | N/A |
| 6/30/2019 | N/A | -10 | -5 | -5 | N/A |
| 3/31/2019 | N/A | -11 | -6 | -6 | N/A |
| 12/31/2018 | N/A | -7 | -6 | -6 | N/A |
| 9/30/2018 | 8 | -1 | -1 | -1 | N/A |
| 6/30/2018 | 8 | -2 | -1 | -1 | N/A |
| 3/31/2018 | 8 | -3 | 0 | 0 | N/A |
| 12/31/2017 | 8 | -4 | 1 | 1 | N/A |
| 9/30/2017 | 3 | -12 | -8 | -8 | N/A |
| 6/30/2017 | 3 | -13 | -7 | -7 | N/A |
| 3/31/2017 | 3 | -58 | -7 | -7 | N/A |
| 12/31/2016 | 3 | -58 | N/A | -9 | N/A |
| 9/30/2016 | N/A | -57 | N/A | -5 | N/A |
| 6/30/2016 | N/A | -60 | N/A | -6 | N/A |
| 3/31/2016 | N/A | -14 | N/A | -5 | N/A |
| 12/31/2015 | N/A | -13 | N/A | -5 | N/A |
| 9/30/2015 | N/A | -13 | N/A | -7 | N/A |
| 6/30/2015 | N/A | -11 | N/A | -8 | N/A |
| 3/31/2015 | N/A | -13 | N/A | -11 | N/A |
| 12/31/2014 | N/A | -14 | N/A | -13 | N/A |
| 9/30/2014 | N/A | -14 | N/A | -12 | N/A |
| 6/30/2014 | N/A | -13 | N/A | -12 | N/A |
| 3/31/2014 | 1 | -11 | N/A | -9 | N/A |
| 12/31/2013 | 1 | -9 | N/A | -6 | N/A |
| 9/30/2013 | 1 | -7 | N/A | -5 | N/A |
| 6/30/2013 | 1 | -6 | N/A | -5 | N/A |
| 3/31/2013 | 0 | -6 | N/A | -5 | N/A |
| 12/31/2012 | 0 | -6 | N/A | -6 | N/A |
| 9/30/2012 | 0 | -6 | N/A | -6 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: 3XB0 is forecast to remain unprofitable over the next 3 years.
수익 vs 시장: 3XB0 is forecast to remain unprofitable over the next 3 years.
고성장 수익: 3XB0 is forecast to remain unprofitable over the next 3 years.
수익 대 시장: 3XB0's revenue (7% per year) is forecast to grow faster than the German market (4.6% per year).
고성장 수익: 3XB0's revenue (7% per year) is forecast to grow slower than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: Insufficient data to determine if 3XB0's Return on Equity is forecast to be high in 3 years time